Overexpression of Regucalcin Suppresses the Growth of Human Osteosarcoma Cells


Journal

Cancer investigation
ISSN: 1532-4192
Titre abrégé: Cancer Invest
Pays: England
ID NLM: 8307154

Informations de publication

Date de publication:
Jan 2020
Historique:
pubmed: 24 12 2019
medline: 9 4 2020
entrez: 24 12 2019
Statut: ppublish

Résumé

Regucalcin plays a pivotal role as a suppressor of human carcinogenesis, and downregulation of regucalcin expression may contribute to the promotion of human osteosarcoma. Overexpression of regucalcin suppressed the proliferation of Saos-2 human osteosarcoma cells

Identifiants

pubmed: 31868021
doi: 10.1080/07357907.2019.1708924
doi:

Substances chimiques

Calcium-Binding Proteins 0
Intracellular Signaling Peptides and Proteins 0
RGN protein, human 0
Carboxylic Ester Hydrolases EC 3.1.1.-
Rgn protein, rat EC 3.1.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

37-51

Auteurs

Masayoshi Yamaguchi (M)

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.

Tomiyasu Murata (T)

Laboratory of Analytical Neurosciences, Faculty of Pharmacy, Meijo University, Tempaku, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH